These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15256400)

  • 1. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.
    Trogan E; Fayad ZA; Itskovich VV; Aguinaldo JG; Mani V; Fallon JT; Chereshnev I; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1714-9. PubMed ID: 15256400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
    ZHAO R; YAO YY; DENG G; JU SH; WANG ZJ; WEN S; CHEN J; JIN H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
    Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
    Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.
    Reis ED; Li J; Fayad ZA; Rong JX; Hansoty D; Aguinaldo JG; Fallon JT; Fisher EA
    J Vasc Surg; 2001 Sep; 34(3):541-7. PubMed ID: 11533609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial, noninvasive, in vivo magnetic resonance microscopy detects the development of atherosclerosis in apolipoprotein E-deficient mice and its progression by arterial wall remodeling.
    Choudhury RP; Fayad ZA; Aguinaldo JG; Itskovich VV; Rong JX; Fallon JT; Fisher EA
    J Magn Reson Imaging; 2003 Feb; 17(2):184-9. PubMed ID: 12541225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.
    Coleman R; Hayek T; Keidar S; Aviram M
    Acta Histochem; 2006; 108(6):415-24. PubMed ID: 17007910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice.
    Wientgen H; Thorngate FE; Omerhodzic S; Rolnitzky L; Fallon JT; Williams DL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1460-5. PubMed ID: 15178566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Higashi K; Kihara T; Sawada S; Iwamoto N; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    J Am Coll Cardiol; 2005 Mar; 45(5):733-42. PubMed ID: 15734619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI.
    Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Kihara T; Tanaka N; Nakaya K; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):222-8. PubMed ID: 19242355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
    Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
    J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
    Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
    Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage apolipoprotein E reduces atherosclerosis and prevents premature death in apolipoprotein E and scavenger receptor-class BI double-knockout mice.
    Yu H; Zhang W; Yancey PG; Koury MJ; Zhang Y; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):150-6. PubMed ID: 16269665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
    Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.
    Lutgens E; Lutgens SP; Faber BC; Heeneman S; Gijbels MM; de Winther MP; Frederik P; van der Made I; Daugherty A; Sijbers AM; Fisher A; Long CJ; Saftig P; Black D; Daemen MJ; Cleutjens KB
    Circulation; 2006 Jan; 113(1):98-107. PubMed ID: 16365196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice.
    Olesen M; Kwong E; Meztli A; Kontny F; Seljeflot I; Arnesen H; Lyngdorf L; Falk E
    Scand Cardiovasc J; 2002 Dec; 36(6):362-7. PubMed ID: 12626204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
    Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
    J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.